IND Safety Reporting Requirements in U.S. Clinical Trials
IND Safety Reporting Requirements in U.S. Clinical Trials Navigating IND Safety Reporting Requirements in U.S. Clinical Trials Introduction Safety reporting is one of the most critical obligations in clinical trials, ensuring that regulators, investigators, and participants are informed of emerging risks. In the United States, the Food and Drug Administration (FDA) has established specific requirements…
Read More “IND Safety Reporting Requirements in U.S. Clinical Trials” »